Alkermes, Inc.

Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders.

Ticker:
ALKS
Exchange:
NASDAQ (See More NASDAQ Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?